34 research outputs found
Perkawinan Usia Dini Perempuan Korowai di Kampung Kabuage Distrik Firiwage Kabupaten Boven Digoel
This study aims to determine the form of early marriage among Korowai women and want to know the factors that influence the occurrence of early marriage for Korowai women in Kabuage village, Firiwage district, Boven Digoel district. The research method used is descriptive-qualitative method, because this method is considered capable of analyzing social reality in detail. Research informants include women who marry early, traditional parents, men and the village head. Data collection was carried out using literature study and field study techniques which included observation, interviews and literature studies. In analyzing the data, three lines of interactive analysis were used, namely data reduction, data presentation and conclusion drawing. The results showed that there were two forms of early marriage in women, namely the form of coercion and without coercion and the driving factors for early marriage in women in Kabuage Village were cultural, educational, economic and modernization factors. The conclusions and suggestions of this study are that early marriage among Korowai women in Kabuage Village, Firiwage District, Boven Digoel Regency occurs in the form of coercion and without coercion which generally occurs due to cultural, educational, economic and modernization factors. Then the suggestion that can be given is the need for the involvement of the Office of Women Empowerment and Family Planning (KB) in Boven Digoel Regency to suppress marriage at an early age. So, it can provide a good understanding to parents, community and traditional leaders. As well as creating more opportunities for girls to obtain rights in accordance with the Rights of the Child Convention. As well as the need for the efforts of various agencies to work together to help human resources in Kabuage Village
Recommended from our members
Intravenous immunoglobulin treatment following the first demyelinating event suggestive of multiple sclerosis: A randomized, double-blind, placebo-controlled trial
Intravenously administered immunoglobulin (IVIg) treatment has been reported to be beneficial in the treatment of patients with relapsing-remitting multiple sclerosis. The goal of this study was to evaluate the effect of IVIg treatment in patients after the first neurological event suggestive of demyelinative disease. The authors conducted a randomized, placebo-controlled, double-blind study in 91 patients enrolled within the first six weeks of neurological symptoms. All patients had an abnormal MRI. Patients were randomly assigned to receive IVIg treatment (2-g/kg loading dose) or placebo, with boosters (0.4 g/kg) given once every six weeks for one year. Neurological and clinical assessments were done every three months, and brain magnetic resonance imaging was performed at baseline and the end of the study (one year).The cumulative probability of developing clinically definite multiple sclerosis was significantly lower in the IVIg treatment group compared with the placebo group (rate ratio, 0.36 [95% confidence interval, 0.15-0.88]; P = .03). Patients in the IVIg treatment group had a significant reduction in the volume and number of T2-weighted lesions and in the volume of gadolinium-enhancing lesions as compared with the placebo group (P = .01, P = .01, and P = .03, respectively). Treatment was well tolerated, compliance was high, and incidence of adverse effects did not differ significantly between groups. The authors conclude that IVIg treatment for the first year from onset of the first neurological event, suggestive of demyelinative disease, significantly lowers the incidence of a second attack and reduces disease activity as measured by brain magnetic resonance imaging